Full-Time

Associate Director

Genomic Assay Research and Development

Confirmed live in the last 24 hours

Element Biosciences

Element Biosciences

201-500 employees

Next-generation sequencing technology provider

Biotechnology
Healthcare

Compensation Overview

$167k - $197kAnnually

+ Stock Options + Bonus

Senior

San Diego, CA, USA

This role is based in San Diego.

Category
Genomics
Biology Lab & Research
Biology & Biotech
Required Skills
Python
R
Data Analysis
Requirements
  • Ph.D. with 8+ years’ industry experience in molecular biology, biochemistry, genomics, chemistry, or related field with a minimum of 3 years in a leadership role managing scientists
  • Demonstrated technical expertise and innovation via publications, IP filing, and product launch
  • Extensive experience in nucleic acid process and manipulation, NGS library prep workflows, spatial genomics, proteomics, and NGS sequencing platforms, etc
  • Experienced user in bioinformatics and data analysis tools, e.g. Python, R, ImageJ, JMP, etc
  • Strong leadership capabilities and the ability to lead multiple projects through a complex development program in fast pace environments
Responsibilities
  • Keep current with the field of genomics, especially NGS methodologies and IP landscape
  • Lead the NGS research studies and technology innovations. Contribute to strategic genomic application roadmap
  • Explore and test feasibility of novel methods to facilitate biological and genetic studies. Bring concept projects to full feasibility and/or through the complete product development phases in extremely short timeline
  • Lead assay development and overcome technical difficulties with creative ideas
  • Guide scientists and research associates from cross functional groups
  • Fully involved in detailed experimental design, execution, data analysis/interpretation, and drawing comprehensive conclusions
  • Deliver multiple research and product development projects on time
  • Provide strong technical leadership in cross-functional environment at the interfaces of life sciences, chemistry, biochemistry, system integration, operation/manufacturing, and engineering
  • Deeply involved in project planning and results tracking with details and communicate complex development challenges in a clear and timely manner
  • Generate high quality scientific data and reports; File IP applications and invention disclosure
  • Live Element values and grow a strong R&D team with the drive for excellence

Element Biosciences specializes in next-generation sequencing (NGS) technology, primarily through its product, the AVITI System. This compact benchtop system provides high-quality DNA sequencing at a low cost, charging only $1 per million reads, which is significantly less than the industry average. The AVITI System is designed to deliver industry-leading accuracy, allowing users, including academic researchers and pharmaceutical companies, to maximize their resources. Element Biosciences differentiates itself from competitors by offering a cost-effective solution and establishing partnerships with other biotech firms, such as QIAGEN, to provide complete NGS workflows. Additionally, the company runs the 2023 AVITI for All Grant program, which offers free sequencing for various applications, further promoting research and demonstrating the AVITI System's capabilities. The goal of Element Biosciences is to make high-quality sequencing accessible and affordable for a wide range of users.

Company Stage

Series D

Total Funding

$659.5M

Headquarters

San Diego, California

Founded

2017

Growth & Insights
Headcount

6 month growth

10%

1 year growth

17%

2 year growth

28%
Simplify Jobs

Simplify's Take

What believers are saying

  • Element Biosciences' recent $277M Series D funding round underscores strong investor confidence and provides substantial resources for growth and innovation.
  • The rapid growth in AVITI System installations, from 20 to over 150 units in a year, indicates strong market adoption and customer satisfaction.
  • The introduction of AVITI24 and Trinity platforms positions Element Biosciences at the forefront of multi-omics and targeted sequencing, potentially revolutionizing research capabilities.

What critics are saying

  • The competitive landscape in NGS technology is intense, with established players potentially overshadowing Element Biosciences' market presence.
  • Rapid expansion and scaling may strain operational capabilities and affect product quality or customer support.

What makes Element Biosciences unique

  • Element Biosciences offers the AVITI System, which provides high-quality sequencing at a significantly lower cost than industry standards, making advanced sequencing more accessible.
  • Strategic partnerships with companies like QIAGEN and Twist Bioscience enhance the AVITI System's capabilities, offering comprehensive NGS workflows and exome sequencing solutions.
  • The company's grant program, AVITI for All, democratizes access to sequencing technology, showcasing the system's capabilities and fostering innovation across various fields.

Help us improve and share your feedback! Did you find this helpful?

Benefits

100% company-paid medical, dental, & vision coverage

Flexible spending & health savings accounts

Premier mental health care

401(k) with immediately vested 4% company match

Company-paid Life and AD&D insurance

Stock option grants

Flexible time off

10 paid annual holidays

8-weeks paid parental leave